DK1292673T3 - Trombomodulinanaloger til farmaceutisk anvendelse - Google Patents

Trombomodulinanaloger til farmaceutisk anvendelse

Info

Publication number
DK1292673T3
DK1292673T3 DK01948487T DK01948487T DK1292673T3 DK 1292673 T3 DK1292673 T3 DK 1292673T3 DK 01948487 T DK01948487 T DK 01948487T DK 01948487 T DK01948487 T DK 01948487T DK 1292673 T3 DK1292673 T3 DK 1292673T3
Authority
DK
Denmark
Prior art keywords
pharmaceutical use
thrombomodulin
thrombin
analogs
thrombomodulin analogues
Prior art date
Application number
DK01948487T
Other languages
Danish (da)
English (en)
Inventor
David Light
Michael John Morser
Mariko Nagashima
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Application granted granted Critical
Publication of DK1292673T3 publication Critical patent/DK1292673T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/7455—Thrombomodulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK01948487T 2000-06-21 2001-06-20 Trombomodulinanaloger til farmaceutisk anvendelse DK1292673T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21367800P 2000-06-21 2000-06-21
US09/880,484 US6632791B1 (en) 2000-06-21 2001-06-12 Thrombomodulin analogs for pharmaceutical use

Publications (1)

Publication Number Publication Date
DK1292673T3 true DK1292673T3 (da) 2006-03-27

Family

ID=26908302

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01948487T DK1292673T3 (da) 2000-06-21 2001-06-20 Trombomodulinanaloger til farmaceutisk anvendelse

Country Status (10)

Country Link
US (2) US6632791B1 (fr)
EP (1) EP1292673B1 (fr)
JP (1) JP4855627B2 (fr)
AT (1) ATE309339T1 (fr)
AU (1) AU2001269927A1 (fr)
DE (1) DE60114819T2 (fr)
DK (1) DK1292673T3 (fr)
ES (1) ES2256266T3 (fr)
NO (1) NO20026147L (fr)
WO (1) WO2001098352A2 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030118580A1 (en) * 2001-11-09 2003-06-26 Rasmus Rojkjaer Pharmaceutical composition comprising factor VII polypeptides and thrombomodulin polypeptides
UA81114C2 (en) 2002-05-01 2007-12-10 Schering Ag Novel antibodies to tissue factor as anticoagulants
US7579000B2 (en) 2002-05-01 2009-08-25 Bayer Schering Pharma Ag Tissue factor targeted antibodies as anticoagulants
US8012693B2 (en) 2003-12-16 2011-09-06 3M Innovative Properties Company Analysis of chemically crosslinked cellular samples
US7833978B2 (en) 2004-02-20 2010-11-16 Emory University Thrombomodulin derivatives and conjugates
JP2009511067A (ja) 2005-10-14 2009-03-19 メディミューン，エルエルシー 抗体ライブラリーの細胞提示
EP2120049A1 (fr) 2008-05-14 2009-11-18 PAION Deutschland GmbH Thrombomoduline soluble en tant que marqueur biologique dans des traitements utilisant des inhibiteurs de coagulation
EA201170201A1 (ru) * 2008-07-16 2011-08-30 Пайон Дойчланд Гмбх Предотвращение и лечение радиационного поражения
WO2010006635A1 (fr) * 2008-07-16 2010-01-21 Paion Deutschland Gmbh Traitement des infections intestinales inflammatoires
US20120165244A1 (en) * 2008-10-30 2012-06-28 Hua-Lin Wu Methods for binding lewis y antigen
US20120270789A1 (en) * 2009-06-12 2012-10-25 Paion Deutschland Gmbh Treatment of coagulopathy with hyperfibrinolysis
EP2600891B1 (fr) 2010-08-05 2018-01-17 Council of Scientific & Industrial Research Protéines de fusion recombinants possédant des propriétés thrombolytiques et anticoagulantes
WO2014020183A1 (fr) * 2012-08-03 2014-02-06 Ici Immunochemical Intelligence Gmbh Essai de diagnostic in vitro de troubles de l'hémostase
US9156904B2 (en) * 2013-07-29 2015-10-13 Blue Blood Biotech Corp. Thrombomodulin variants and use thereof
WO2017189943A1 (fr) * 2016-04-28 2017-11-02 Saint Louis University Protéines de fusion thrombine-thrombomoduline utilisées en tant que puissant anticoagulant

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5256770A (en) 1990-04-09 1993-10-26 Schering Ag Oxidation resistant thrombomodulin analogs
US6063763A (en) 1989-04-28 2000-05-16 Schering Aktiengesellschaft Protease-resistant thrombomodulin analogs
US5466668A (en) 1989-04-28 1995-11-14 Schering Aktiengesellschaft Superior thrombomodulin analogs for pharmaceutical use
WO1993025675A1 (fr) * 1992-06-10 1993-12-23 Schering Aktiengesellschaft Mutants des domaines du facteur de croissance epidermique de la thrombomoduline humaine

Also Published As

Publication number Publication date
ES2256266T3 (es) 2006-07-16
EP1292673B1 (fr) 2005-11-09
US20030186883A1 (en) 2003-10-02
NO20026147D0 (no) 2002-12-20
US6632791B1 (en) 2003-10-14
EP1292673A2 (fr) 2003-03-19
WO2001098352A2 (fr) 2001-12-27
ATE309339T1 (de) 2005-11-15
JP2004527452A (ja) 2004-09-09
US6790828B2 (en) 2004-09-14
DE60114819T2 (de) 2006-08-10
WO2001098352A3 (fr) 2002-08-01
AU2001269927A1 (en) 2002-01-02
NO20026147L (no) 2003-02-20
JP4855627B2 (ja) 2012-01-18
DE60114819D1 (de) 2005-12-15

Similar Documents

Publication Publication Date Title
DK1292673T3 (da) Trombomodulinanaloger til farmaceutisk anvendelse
TR200200768T2 (tr) Yeni kuinüklidin türevleri ve bunu içeren ilaç bileşimleri
IL232501A (en) Peptide or polypeptide-resistant protein analogs and their uses
CY1111225T1 (el) Νεα πεπτιδια ως αναστολεις πρωτεασης νs3-σερινης ιου ηπατiτιδας c
CY1112267T1 (el) Νεα πεπτιδια ως αναστολεις πρωτεασης ns3-σερινης του ιου ηπατιτιδας c
NO20071077L (no) Fosfonatanaloger til HIV-inhibitorforbindelser
MXPA04003333A (es) Remodelado y glicoconjugacion de peptidos.
DK1290011T3 (da) Melphalan-derivater og deres anvendelse som cancer-kemoterapeutiske lægemidler
EA200300937A1 (ru) Оральная фармацевтическая композиция цефподоксима проксетила
NO20053111L (no) Peptider som inhiberer angiogenese, cellemigrering, celleinvasjon og celleproliferering.
PT1268498E (pt) Fosfonatos cardioprotectores
ATE282607T1 (de) Tryptase-inhibitoren
IL165988A0 (en) Process for the preparation of fibrinogen
DK0973544T3 (da) Immuntolerant prothrombinkomplekspræparat
DE502004011395D1 (de) Protein-bindende doxorubicin-peptid-derivate
RS83104A (en) Process to prepare eplerenone
AU8184301A (en) Inhibitors for the blood-clotting factor xa
TR200102514T2 (tr) COPD tedavisi için metod
DE59809283D1 (de) Inhibitoren für den urokinaserezeptor
IS7200A (is) Notkun á írbesartan til framleiðslu á lækningalyfjum sem notuð eru til að koma í veg fyrir eða meðhöndla lungnaháþrýsting
HUP0301523A2 (hu) VEGF-peptidek és alkalmazásuk angiogenezis gátlására
DE60031422D1 (de) Peptidanaloge als selektive inhibitoren der thrombinaktivierung des durch protease aktivierten rezeptors
NO20024363L (no) Nye LHRH-antagonister, produksjon og anvendelse av disse som medikamant
NO20033413D0 (no) Krystallmodifisering av et syklisk depsipeptid med forbedret aktivitet
GB0221169D0 (en) Crystal